Product Theatre
Friday, 29 April
10:35 – 10:45
Vaginal microbiota and genital pathogens during pregnancy in
Pemba island, Tanzania
Elena Ambrosino, Maastricht University, Netherlands
10:45 – 10:55
NTCD-M3 for prevention of recurrence of C. difficile infection
Stephanie Bewick, Destiny Pharma plc, United Kingdom
13:50 – 14:00
Utilising Metagenomics in Early to Late-Stage R&D
Jennifer Mackay, CosmosID, UK
14:00 – 14:10
Ferring and Microbiome
Kristin Wannerberger, Ferring Pharmaceuticals, Switzerland
14:10 – 14:20
Advancing Microbiome-Nutrition-Disease Interactions Research and
Discovery Using Large Cohorts
Yossi Cohen, Day Two, Israel
Saturday, 30 April
10:20 – 10:30
Microba’s Discovery Platform – A unique dataset for discovery
Mark Parker, Microba, Australia
10:30 – 10:35
Nontargeted LC-MS analysis of microbial metabolism
Ville Koistinen, Afekta Technologies Ltd, Finland






